Evidence map›Paper›PMID 23757291›Full record

ReviewSeminars in immunology2013

Carbohydrates and T cells: a sweet twosome.

Fikri Y Avci, Xiangming Li, Moriya Tsuji, Dennis L Kasper

Open access · greenAbstract readReview
In one paragraph

Review in Seminars in immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. Review
  3. Semisynthetic Glycoconjugate Vaccine Lead againstJournal of the American Chemical Society · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Glycoconjugate Vaccines for Prevention ofRussian journal of bioorganic chemistry · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Fikri Y AvciDivision of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA. fikri_avci@hms.harvard.edu
Xiangming Li
Moriya Tsuji
Dennis L Kasper
Harvard University · USRockefeller University · US

Funding

CD1d/NKT-binding glycolipids in enhancing the immunogenicity of a malaria vaccineR01AI070258 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI TSUJI, MORIYA · 2012 to 2016
$2.2M
Knowledge-based Vaccines Built on Paradigm Changes in Antigen PresentationR01AI089915 · NIAID · HARVARD MEDICAL SCHOOL · PI KASPER, DENNIS L. · 2011 to 2015
$2.1M
Optimizing adenoviral vector to elicit a potent anti-malaria immunityR01AI081510 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI TSUJI, MORIYA · 2009 to 2012
$1.8M
CD1d/NKT-binding Glycolipids as an Adjuvant for a T cell-based Malaria VaccineR56AI070258 · NIAID · AARON DIAMOND AIDS RESEARCH CENTER · PI TSUJI, MORIYA · 2008 to 2009
$934k
NIAID NIH HHS AI-070258NIAID NIH HHS AI-081510NIAID NIH HHS AI-089915NIAID NIH HHS R01 AI070258NIAID NIH HHS R01 AI081510NIAID NIH HHS R01 AI089915NIAID NIH HHS R56 AI070258
6 · The paper itself

Abstract

Carbohydrates as T cell-activating antigens have been generating significant interest. For many years, carbohydrates were thought of as T-independent antigens, however, more recent research had demonstrated that mono- or oligosaccharides glycosidically linked to peptides can be recognized by T cells. T cell recognition of these glycopeptides depends on the structure of both peptide and glycan portions of the antigen. Subsequently, it was discovered that natural killer T cells recognized glycolipids when presented by the antigen presenting molecule CD1d. A transformative insight into glycan-recognition by T cells occurred when zwitterionic polysaccharides were discovered to bind to and be presented by MHCII to CD4+ T cells. Based on this latter observation, the role that carbohydrate epitopes generated from glycoconjugate vaccines had in activating helper T cells was explored and it was found that these epitopes are presented to specific carbohydrate recognizing T cells through a unique mechanism. Here we review the key interactions between carbohydrate antigens and the adaptive immune system at the molecular, cellular and systems levels exploring the significant biological implications in health and disease.

Indexed as

Vaccines, ConjugateAdaptive ImmunityAnimalsAntigen PresentationAntigens, CD1dCarbohydratesHumansLymphocyte ActivationT-LymphocytesAntigens, CD1dCarbohydratesVaccines, ConjugateAntigen presentationantigen-presenting cellsAPCsB-cell receptorBCRcapsular polysaccharidesCPSsDCsdendritic cellsGBSIIIGlycoconjugate vaccineGlycolipidGlycopeptideIBDIFN-γILinducible nitric oxide synthaseinflammatory bowel diseaseiNKTiNOSinterferon γinterleukininvariant natural-killer Tmajor histocompatibility class IIMHCIIOVAovalbuminpolysaccharide APSAreactive nitrogen speciesRNSsTcarbsT cellT-cell receptorT cells that recognize carbohydrates onlyTCRtetanus toxoidTTtype III polysaccharide of group B StreptococcusZPSsZwitterionic polysaccharidezwitterionic polysaccharidesα-galactosylceramide.α-GalCer

Identifiers

PMID23757291
PMCPMC3752327
OpenAlexW1984081705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.